The novel progestin drospirenone and its natural counterpart progesterone: Biochemical profile and antiandrogenic potential
about
Drospirenone and its antialdosterone propertiesA computational approach to finding novel targets for existing drugsDifferential effects of 17beta-estradiol and of synthetic progestins on aldosterone-salt-induced kidney diseaseHormone replacement therapy with estradiol and drospirenone: an overview of the clinical data.A combined oral contraceptive containing 30 mcg ethinyl estradiol and 3.0 mg drospirenone does not impair endothelium-dependent vasodilation.Efficacy and safety of combined ethinyl estradiol/drospirenone oral contraceptives in the treatment of acne.Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effectsOral contraceptives and mood.New progestagens for contraceptive use.The renin-aldosterone system and drospirenone.Menstrual effects on mood symptoms in treated women with bipolar disorderAndrogens and adipose tissue in males: a complex and reciprocal interplay.A new highly specific and robust yeast androgen bioassay for the detection of agonists and antagonistsFourth-Generation Progestins Inhibit 3β-Hydroxysteroid Dehydrogenase Type 2 and Modulate the Biosynthesis of Endogenous Steroids.Drospirenone and estradiol: a new option for the postmenopausal woman.Drospirenone with 17beta-estradiol in the postmenopausal woman with hypertension.Effects of blood pressure reduction on cardiovascular risk estimates in hypertensive postmenopausal women.Drospirenone: a novel progestin.Short-term effects of low-dose estrogen/drospirenone vs low-dose estrogen/dydrogesterone on glycemic fluctuations in postmenopausal women with metabolic syndrome.Effects of drospirenone pill in Indian women with polycystic ovary syndrome.A review of the cardiovascular and breast actions of drospirenone in preclinical studies.Efficacy and safety of drospirenone 2 mg/17β-estradiol 1 mg hormone therapy in Korean postmenopausal women.Drospirenone/ethinylestradiol: a review on efficacy and noncontraceptive benefits.The combined oral contraceptive pill containing drospirenone and ethinyl estradiol plus levomefolate calcium.Contraceptives with novel benefits.Beyaz®: an oral contraceptive fortified with folate.Comprehensive evaluation of Safyral(®) 2012.Hormonal contraception: venous and arterial disease.Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone.Combination of drospirenone and estradiol: a new hormone therapy in postmenopausal women.Ethinyl estradiol/drospirenone for the treatment of the emotional and physical symptoms of premenstrual dysphoric disorder.Yasminelle((R)): a new low-dose combined oral contraceptive containing drospirenone.A 1-year pharmacokinetic investigation of a novel oral contraceptive containing drospirenone in healthy female volunteers.Safety and efficacy of drospirenone used in a continuous combination with 17beta-estradiol for prevention of postmenopausal osteoporosis.Estradiol and drospirenone for climacteric symptoms in postmenopausal women: a double-blind, randomized, placebo-controlled study of the safety and efficacy of three dose regimens.One-year randomized study of the endometrial safety and bleeding pattern of 0.25 mg drospirenone/0.5 mg 17β-estradiol in postmenopausal women.Treatment of hirsutism with combined pill containing drospirenone.Pharmacokinetics and pharmacodynamics of drospirenone-estradiol combination hormone therapy product coadministered with hydrochlorothiazide in hypertensive postmenopausal women.Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized study.A Canadian multicentre prospective study on the effects of an oral contraceptive containing 3 mg drospirenone and 30 microg ethinyl oestradiol on somatic and psychological symptoms related to water retention and on body weight.
P2860
Q28293272-AD84FDB8-1ACD-4BE8-A5A3-034347246135Q28476770-CF0EEDCF-CCB3-4425-8761-65ED4B50067AQ28569728-C2F978BE-57BF-48FE-AF45-AAA3A82493A1Q31033397-9A6B2415-27F6-4ABA-94D8-05D6D0636CC8Q34145361-1AE2DD8F-5F94-48D7-A203-ECEABC75498CQ34271948-9EABE5EE-D7E5-46CC-BC9A-9316F7206F03Q34317537-A7CA6AA0-67E3-466C-9128-8C0EBA6B44C5Q34390323-313FCC21-B6F3-48B7-A155-76FD04A82708Q34468158-5DA687D7-4E0F-4B17-B378-80544DBA9CDDQ34577750-BB760614-C4C8-4830-9B8F-C5B507C54C4EQ35051425-AB5EF8CE-3D9D-4A23-8C65-6A1E064FB83DQ35659922-518563DB-F851-42D5-8538-2DAD865BF81DQ36098223-57143ED8-D074-4F23-B0C8-7BAD4C6685D7Q36153866-4C46D518-8B28-482D-AD50-C87099933E18Q36761429-7E43D017-2AA3-46E7-A0BE-F2DEE5866104Q36761438-3D62D263-62FD-48D9-B929-F5BFDBA0AE26Q36761442-A0BE2095-045E-4671-9839-F953A9C6B3FAQ36808051-17C0BE05-54E0-41B5-BD54-935AC41CD385Q37471083-5F7769C1-5A4C-4622-A009-F8DE40C1FEAFQ37611368-098A3D28-6533-4A18-9F12-95059412F82FQ37638712-15C6F8DC-8522-41AE-B702-39D9DCD8D59CQ37718913-9C33988B-4722-4292-95C0-D56ED35E8059Q37822793-F7FB2F15-EA8C-4B89-9808-E02EF52412E6Q37923956-4D0B0DCB-B360-4D85-91D1-A2F93FC2B8C6Q37965736-4FD50A4A-F32F-4B56-B415-BD68960FBA34Q37968645-229D9FE5-310E-4571-9B40-FC2E92B47A40Q38062561-3B33C1BB-8C65-4EAC-80A8-5861E635B582Q38870757-6DB2F86C-CDF5-4728-BE32-DC0EF1285AF8Q42627292-C045D3F6-7BF4-4B6F-B5FB-B823301FF148Q43267025-D7CF9F3B-B345-40E4-8895-ECA42B980657Q43267026-F67C53CA-F305-406B-B94D-3018AC1A82D2Q43267039-AB213E97-099C-4B4D-8AD5-FABF4351F440Q43540311-AF03636D-723B-48B5-85F5-DBA00B29C34EQ44982985-43EB17D2-7348-4809-B5DA-4CB460026BC1Q45118185-B722699F-634D-44D1-AF98-6DCCBB403DFBQ45394890-F8CB14D6-B803-4B20-A3D5-616D3D788E13Q46669113-25F14527-E49E-483B-A797-7191AE71A3FDQ46974098-6C11CC29-E208-4DE4-B646-62EFB828951BQ47206352-BEA8C579-560A-48D7-B45A-CF5C65186CF4Q47272322-464E2804-37B7-4F8C-A747-410361823122
P2860
The novel progestin drospirenone and its natural counterpart progesterone: Biochemical profile and antiandrogenic potential
description
1996 nî lūn-bûn
@nan
1996 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
The novel progestin drospireno ...... e and antiandrogenic potential
@ast
The novel progestin drospireno ...... e and antiandrogenic potential
@en
type
label
The novel progestin drospireno ...... e and antiandrogenic potential
@ast
The novel progestin drospireno ...... e and antiandrogenic potential
@en
prefLabel
The novel progestin drospireno ...... e and antiandrogenic potential
@ast
The novel progestin drospireno ...... e and antiandrogenic potential
@en
P2093
P3181
P1433
P1476
The novel progestin drospireno ...... e and antiandrogenic potential
@en
P2093
Emily P. Slater
Karl-Heinrich Fritzemeier
Rolf Krattenmacher
Ulrike Fuhrmann
P304
P3181
P356
10.1016/S0010-7824(96)00195-3
P577
1996-10-01T00:00:00Z